Release Date: 11/03/20 08:35 Summary: FDA Establishes INAD for CPAT-01 Price Sensitive: Yes Download Document 191.47KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%